Contact this trialFirst, we need to learn more about you.
Orexin Antagonist
Suvorexant for Opioid Use Disorder
Recruiting0 awardsPhase 2
Baltimore, Maryland
This trial is investigating whether the orexin neurotransmitter system is linked to sleep disturbance and stress in opioid use disorder patients who are early in their recovery and on medication assisted treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service